Ionis Pharmaceuticals | IONS - Cost Of Sales

Stock Price
74.80
Daily Change
0.96 1.30%
Monthly
0.03%
Yearly
123.28%
Q2 Forecast
72.74

Ionis Pharmaceuticals reported $3M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Agios Pharmaceuticals USD 1.32M 560K Mar/2026
Alnylam Pharmaceuticals USD 211.12M 56.6M Mar/2026
Astellas Pharma JPY 129.43B 19.7B Mar/2026
BioCryst Pharmaceuticals USD 9.52M 7.34M Dec/2025
BioMarin Pharmaceutical USD 199.48M 37.93M Mar/2026
Celltrion KRW 107.42B 295.44B Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Esperion Therapeutics USD 27.85M 13.43M Dec/2025
Exelixis USD 19.95M 6.53M Mar/2026
Halozyme Therapeutics USD 108.75M 6.6M Mar/2026
Ionis Pharmaceuticals USD 3M 5M Mar/2026
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Medical Developments International AUD 7.09M 4.91M Dec/2025
Moderna USD 955M 503M Mar/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Neurocrine Biosciences USD 13.8M 3.8M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Omeros USD 33.16M 18.52M Jun/2024
OPKO Health USD 103.48M 1.3M Dec/2025
Organigram Holdings CAD 56.93M 20.53M Dec/2025
Pfizer USD 4.59B 1.7B Mar/2026
Pharma Mar EUR 3.66M 116K Mar/2026
PTC Therapeutics USD 39.61M 23.31M Mar/2026
Qiagen NV USD 217.43M 29.65M Dec/2025
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sarepta Therapeutics USD 109.46M 289.93M Mar/2026
Sartorius EUR 484.6M 46.6M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Tilray USD 164.37M 8.41M Sep/2025
Ultragenyx Pharmaceutical USD 30M 1000K Mar/2026
Vertex Pharmaceuticals USD 392.8M 73.2M Mar/2026
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026